Gold Coast, Queensland; and Sydney, New South Wales, Australia; St Louis, Mo.; and Dallas, Texas
From the Griffith University; Australian Breast Device Registry, Monash University; International Collaboration of Breast Device Registries (ICOBRA); Parkcrest Plastic Surgery; University of Texas Southwestern Medical Center; Integrated Specialist Healthcare Education and Research Foundation; and The Global Alliance for Aesthetic Breast Surgery.
Received for publication December 3, 2018; accepted December 17, 2018.
Disclosure:Associate Prof. Magnusson is a consultant, advisor, and educator for Mentor (Johnson & Johnson) and Allergan. Dr. McGuire is a consultant and research coordinator for Allergan. Dr. Adams is a consultant, advisor, and research coordinator for Allergan, Galaflex, Motiva, and Sientra. Professor Anand K. Deva is a consultant, research coordinator, educator for Allergan, Mentor (Johnson & Johnson), Sientra, Motiva and Acelity (KCI). He has previously coordinated industry-sponsored research for these companies relating to both biofilms and breast prostheses. Drs. Cooter and Rakhorst have no financial interest in any of the products, devices, or drugs mentioned in this article.
Mark R. Magnusson, MBBS, FRACS, Griffith University and Towoomba Plastic Surgery, 8 Margaret Street, East Towoomba, QLD, Australia 4350, [email protected], Twitter: @saferimplants, Instagram: @ProfDeva
